Top KHN Original Stories

View More

Total Results: 16294

Early Approval Of Generic MS Drug Signals Big Changes For Teva And Other Drugmakers

KHN Morning Briefing

Teva had lobbied the Food and Drug Administration to reject Mylan’s generic version of its Copaxone multiple sclerosis medication. In other drug industry news: an experimental drug is found to work on a mutant gene; advocates await Calif. Gov. Jerry Brown’s decision on a drug pricing bill; and Cleveland Clinic’s CEO wants supporters of a drug pricing ballot measure in Ohio to stop using his image.